On January 10, 2019, the Board of Directors of Y-mAbs Therapeutics, Inc., elected its members Dr. Ashutosh Tyagi and David N. Gill to serve on the Board’s Nominating and Corporate Governance Committee with effect as of January 10, 2019. Dr. Tyagi and Mr. Gill replace chairman of the Board Thomas Gad and Board member Dr. Greg Raskin as members of the Nominating and Corporate Governance Committee. In addition, Dr. Tyagi will replace Mr. Gad as chairman of the Nominating and Corporate Governance Committee.